Abstract:Objective: To evaluate the genetic contribution of ANXA11 to Chinese amyotrophic lateral sclerosis (ALS) patients with and without cognitive dementia. Background: Recently, ANXA11 gene was identified be associated with ALS patients of European ancestry. However, the pathogenicity of ANXA11 in other ALS cohorts remained unproved. Design/Methods: Sanger sequencing was used to screen all the coding exons of ANXA11 and intron-exon boundaries in 18 familial ALS (FALS), 353 unrelated sporadic ALS (SALS) and 12 amyotrophic lateral sclerosis-frontotemporal lobar dementia (ALS-FTD) patients of Chinese origin. The transcripts in peripheral blood generated from a splicing mutation was examined by reverse transcriptase PCR. Results: We identified 6 nonsynonymous heterozygous mutations (c.107C>G, p.P36R;c.119A>G, p.D40G; c.382G>A, p.V128M; c.687T>A, p.S229R; c.904C>T, p.R302C; c.1471G>A, p.G491R) and 1 splice-site mutation(c.174-2A>G, p.A58_Q187del) in 10 unrelated patients, accounting for a mutant frequency of 5.6% (1/18) in FALS, 2.3% (8/353) in SALS and 8.3% (1/12) in ALS-FTD. A novel p. P36R mutation was identified in one FALS index, one SALS patient and one ALS-FTD. Another ALS patient with documented cognitive decline carried a p.G491R mutation but was lost to follow-up. The splicing mutation (c.174-2A>G) caused in-frame skipping of the entire exon 6 and further supported the loss-of-function mechanism. Conclusions: Our result showed that ANXA11 is the most frequently mutated genes in Chinese patients with SALS. The study findings further expand the ANXA11 phenotype, firstly highlighting its pathogenic role in ALS-FTD. Study Supported by: This study was funded by the National Key Research and Development Program of China (Grant number: 2016YFC0905100), the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS) (Grant number: 2016-I2M-1-002; 2016-12M-1-004), the National Natural Science Foundation of China (NSFC) (Grant number: 81230015), the Beijing Municipal Science and Technology Commission (Grant number: Z151100003915078). Disclosure: Dr. Zhang has nothing to disclose. Dr. Liu has nothing to disclose. Dr. Liu has nothing to disclose. Dr. Shen has nothing to disclose. Dr. Tai has nothing to disclose. Dr. Shu has nothing to disclose. Dr. Ding has nothing to disclose. Dr. Fu has nothing to disclose. Dr. Liu has nothing to disclose. Dr. Wang has nothing to disclose. Dr. LI has nothing to disclose. Dr. Liu has nothing to disclose. Dr. Zhang has nothing to disclose. Dr. Cui has nothing to disclose.

[The Association Between Angiogenin Gene Variations and Familial Amyotrophic Lateral Sclerosis in Chinese Han Patients].

Genetic Spectrum and Variability in Chinese Patients with Amyotrophic Lateral Sclerosis.

ANXA11 Mutations Prevail in Chinese Amyotrophic Lateral Sclerosis Patients with and Without Cognitive Dementia (P1.320)

Angiogenin Variants Are Not Associated with Parkinson'S Disease in the Ethnic Chinese Population

Genotype-phenotype Correlations in a Chinese Population with Familial Amyotrophic Lateral Sclerosis.

[Association Between VAPB Mutations and Familial Amyotrophic Lateral Sclerosis in Chinese Patients].

The rs2619566, rs10260404, and rs79609816 Polymorphisms Are Associated With Sporadic Amyotrophic Lateral Sclerosis in Individuals of Han Ancestry From Mainland China

Two Rare Variants of the ANXA11 Gene Identified in Chinese Patients with Amyotrophic Lateral Sclerosis.

Screening for CCNF Mutations in a Chinese Amyotrophic Lateral Sclerosis Cohort

Concomitant presence of a novel ARPP21 variant and CNVs in Chinese familial amyotrophic lateral sclerosis-frontotemporal dementia patients

Clinical Features and Cu/Zn Superoxide Dismutase Gene Mutations in Two Mainland Chinese Families with Amyotrophic Lateral Sclerosis

Investigation of a Fused in Sarcoma Splicing Mutation in a Chinese Amyotrophic Lateral Sclerosis Patient.

VEGF C2578A Polymorphism Does Not Contribute to Amyotrophic Lateral Sclerosis Susceptibility in Sporadic Chinese Patients

Presence of Rare Variants is Associated with Poorer Survival in Chinese Patients with Amyotrophic Lateral Sclerosis.

Genetic Analysis of Arylsulfatase A (ARSA) in Chinese Patients with Parkinson's Disease.

Potential Common Genetic Risks of Sporadic Parkinson’s Disease and Amyotrophic Lateral Sclerosis in the Han Population of Mainland China

The Single-Nucleotide Polymorphism Rs6690993 in FGGY is Not Associated with Amyotrophic Lateral Sclerosisin a Large Chinese Cohort

Association Between Superoxide Dismutase 1 Mutations and Clinical Phenotypes in Chinese Patients with Familial Amyotrophic Lateral Sclerosis

[Screening of Mutations in SOD1 Gene and Analysis of Genotype-Phenotype Correlation in Chinese Patients with Amyotrophic Lateral Sclerosis].

Erratum: Genome-wide association analyses in Han Chinese identify two new susceptibility loci for amyotrophic lateral sclerosis (Nature Genetics (2013) DOI: 10.1038/ng.2627)

The Epidemiology and Genetics of Amyotrophic Lateral Sclerosis in China